UniProt ID | EPHB3_HUMAN | |
---|---|---|
UniProt AC | P54753 | |
Protein Name | Ephrin type-B receptor 3 | |
Gene Name | EPHB3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 998 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cell projection, dendrite. |
|
Protein Description | Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Generally has an overlapping and redundant function with EPHB2. Like EPHB2, functions in axon guidance during development regulating for instance the neurons forming the corpus callosum and the anterior commissure, 2 major interhemispheric connections between the temporal lobes of the cerebral cortex. In addition to its role in axon guidance plays also an important redundant role with other ephrin-B receptors in development and maturation of dendritic spines and the formation of excitatory synapses. Controls other aspects of development through regulation of cell migration and positioning. This includes angiogenesis, palate development and thymic epithelium development for instance. Forward and reverse signaling through the EFNB2/EPHB3 complex also regulate migration and adhesion of cells that tubularize the urethra and septate the cloaca. Finally, plays an important role in intestinal epithelium differentiation segregating progenitor from differentiated cells in the crypt.. | |
Protein Sequence | MARARPPPPPSPPPGLLPLLPPLLLLPLLLLPAGCRALEETLMDTKWVTSELAWTSHPESGWEEVSGYDEAMNPIRTYQVCNVRESSQNNWLRTGFIWRRDVQRVYVELKFTVRDCNSIPNIPGSCKETFNLFYYEADSDVASASSPFWMENPYVKVDTIAPDESFSRLDAGRVNTKVRSFGPLSKAGFYLAFQDQGACMSLISVRAFYKKCASTTAGFALFPETLTGAEPTSLVIAPGTCIPNAVEVSVPLKLYCNGDGEWMVPVGACTCATGHEPAAKESQCRPCPPGSYKAKQGEGPCLPCPPNSRTTSPAASICTCHNNFYRADSDSADSACTTVPSPPRGVISNVNETSLILEWSEPRDLGGRDDLLYNVICKKCHGAGGASACSRCDDNVEFVPRQLGLTERRVHISHLLAHTRYTFEVQAVNGVSGKSPLPPRYAAVNITTNQAAPSEVPTLRLHSSSGSSLTLSWAPPERPNGVILDYEMKYFEKSEGIASTVTSQMNSVQLDGLRPDARYVVQVRARTVAGYGQYSRPAEFETTSERGSGAQQLQEQLPLIVGSATAGLVFVVAVVVIAIVCLRKQRHGSDSEYTEKLQQYIAPGMKVYIDPFTYEDPNEAVREFAKEIDVSCVKIEEVIGAGEFGEVCRGRLKQPGRREVFVAIKTLKVGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTKSRPVMILTEFMENCALDSFLRLNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDPSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAVEQDYRLPPPMDCPTALHQLMLDCWVRDRNLRPKFSQIVNTLDKLIRNAASLKVIASAQSGMSQPLLDRTVPDYTTFTTVGDWLDAIKMGRYKESFVSAGFASFDLVAQMTAEDLLRIGVTLAGHQKKILSSIQDMRLQMNQTLPVQV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
167 | Phosphorylation | IAPDESFSRLDAGRV ECCCCCCCCCCCCCC | 41.01 | - | |
190 | Phosphorylation | PLSKAGFYLAFQDQG CHHHHCEEEEEECCC | 9.01 | 26074081 | |
201 | Phosphorylation | QDQGACMSLISVRAF ECCCCHHHHHHHHHH | 23.57 | 26074081 | |
204 | Phosphorylation | GACMSLISVRAFYKK CCHHHHHHHHHHHHH | 15.73 | 26074081 | |
209 | Phosphorylation | LISVRAFYKKCASTT HHHHHHHHHHHHCCC | 14.46 | 26074081 | |
249 | Phosphorylation | IPNAVEVSVPLKLYC CCCCEEEEEEEEEEE | 12.43 | - | |
341 | Phosphorylation | SACTTVPSPPRGVIS CCCCCCCCCCCCCCC | 43.11 | 17081983 | |
351 | N-linked_Glycosylation | RGVISNVNETSLILE CCCCCCCCCCEEEEE | 51.59 | UniProtKB CARBOHYD | |
390 | O-linked_Glycosylation | AGGASACSRCDDNVE CCCCHHCCCCCCCCE | 35.34 | 29351928 | |
413 | Phosphorylation | TERRVHISHLLAHTR CCCEEEHHHHHHHCC | 8.00 | - | |
441 | Phosphorylation | KSPLPPRYAAVNITT CCCCCCCEEEEEEEC | 12.51 | 25278378 | |
445 | N-linked_Glycosylation | PPRYAAVNITTNQAA CCCEEEEEEECCCCC | 22.59 | UniProtKB CARBOHYD | |
447 | Phosphorylation | RYAAVNITTNQAAPS CEEEEEEECCCCCCC | 17.94 | 25278378 | |
448 | Phosphorylation | YAAVNITTNQAAPSE EEEEEEECCCCCCCC | 22.87 | 24043423 | |
454 | Phosphorylation | TTNQAAPSEVPTLRL ECCCCCCCCCCEEEE | 46.64 | 25278378 | |
458 | Phosphorylation | AAPSEVPTLRLHSSS CCCCCCCEEEEECCC | 29.68 | 25278378 | |
589 | Phosphorylation | LRKQRHGSDSEYTEK HHHHHCCCCHHHHHH | 31.66 | 26356563 | |
591 | Phosphorylation | KQRHGSDSEYTEKLQ HHHCCCCHHHHHHHH | 33.91 | 26356563 | |
593 | Phosphorylation | RHGSDSEYTEKLQQY HCCCCHHHHHHHHHH | 24.93 | 25884760 | |
594 | Phosphorylation | HGSDSEYTEKLQQYI CCCCHHHHHHHHHHH | 23.69 | 26356563 | |
600 | Phosphorylation | YTEKLQQYIAPGMKV HHHHHHHHHCCCCEE | 6.01 | 21945579 | |
608 | Phosphorylation | IAPGMKVYIDPFTYE HCCCCEEEECCCCCC | 8.29 | 21945579 | |
613 | Phosphorylation | KVYIDPFTYEDPNEA EEEECCCCCCCHHHH | 31.24 | 21945579 | |
614 | Phosphorylation | VYIDPFTYEDPNEAV EEECCCCCCCHHHHH | 20.79 | 21945579 | |
666 | Phosphorylation | EVFVAIKTLKVGYTE HEEEEEEEECCCCCH | 26.21 | 23312004 | |
731 | Phosphorylation | RLNDGQFTVIQLVGM ECCCCCEEHHHHHHH | 14.60 | - | |
748 | Phosphorylation | GIAAGMKYLSEMNYV HHHHHHHHHHHCCCC | 13.43 | 23312004 | |
750 | Phosphorylation | AAGMKYLSEMNYVHR HHHHHHHHHCCCCCH | 31.54 | 23312004 | |
754 | Phosphorylation | KYLSEMNYVHRDLAA HHHHHCCCCCHHHHH | 9.05 | 22817900 | |
768 | Phosphorylation | ARNILVNSNLVCKVS HHCCEECCCEEEEEC | 24.86 | - | |
773 | Ubiquitination | VNSNLVCKVSDFGLS ECCCEEEEECHHCHH | 36.98 | 21987572 | |
775 | Phosphorylation | SNLVCKVSDFGLSRF CCEEEEECHHCHHHH | 16.83 | - | |
780 | Phosphorylation | KVSDFGLSRFLEDDP EECHHCHHHHCCCCC | 22.74 | 19369195 | |
788 | Phosphorylation | RFLEDDPSDPTYTSS HHCCCCCCCCCEECC | 64.32 | 21945579 | |
791 | Phosphorylation | EDDPSDPTYTSSLGG CCCCCCCCEECCCCC | 44.41 | 21945579 | |
792 | Phosphorylation | DDPSDPTYTSSLGGK CCCCCCCEECCCCCC | 15.26 | 21945579 | |
793 | Phosphorylation | DPSDPTYTSSLGGKI CCCCCCEECCCCCCC | 17.83 | 21945579 | |
794 | Phosphorylation | PSDPTYTSSLGGKIP CCCCCEECCCCCCCC | 17.10 | 21945579 | |
795 | Phosphorylation | SDPTYTSSLGGKIPI CCCCEECCCCCCCCE | 24.19 | 21945579 | |
799 | Ubiquitination | YTSSLGGKIPIRWTA EECCCCCCCCEEEEC | 43.44 | 29901268 | |
812 | Phosphorylation | TAPEAIAYRKFTSAS ECCHHHHCCCCCCHH | 14.28 | - | |
891 | Phosphorylation | KFSQIVNTLDKLIRN HHHHHHHHHHHHHHH | 25.99 | 23312004 | |
901 | Phosphorylation | KLIRNAASLKVIASA HHHHHHHHHHHHHHC | 26.72 | - | |
920 | Phosphorylation | SQPLLDRTVPDYTTF CCCCCCCCCCCCCCE | 35.74 | 25106551 | |
924 | Phosphorylation | LDRTVPDYTTFTTVG CCCCCCCCCCEEEHH | 11.12 | 26356563 | |
925 | Phosphorylation | DRTVPDYTTFTTVGD CCCCCCCCCEEEHHH | 23.86 | 26356563 | |
926 | Phosphorylation | RTVPDYTTFTTVGDW CCCCCCCCEEEHHHH | 16.86 | 21082442 | |
953 | Phosphorylation | FVSAGFASFDLVAQM HHHCCCCCHHHHHCC | 19.61 | 19369195 | |
971 | Phosphorylation | DLLRIGVTLAGHQKK HHHHHCCEEHHHHHH | 12.99 | 17192257 | |
993 | Phosphorylation | MRLQMNQTLPVQV-- HHHHHCCCCCCCC-- | 28.20 | 27470641 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
614 | Y | Phosphorylation | Kinase | EPHB3 | P54753 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EPHB3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPHB3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EFNB3_HUMAN | EFNB3 | physical | 9484836 | |
RASA1_HUMAN | RASA1 | physical | 9674711 | |
GLGB_HUMAN | GBE1 | physical | 21988832 | |
NFRKB_HUMAN | NFRKB | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-608; TYR-614; TYR-792AND THR-971, AND MASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-792, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-600, AND MASSSPECTROMETRY. |